SEGMENT INFORMATION (Tables)

6 Months Ended

Jan. 31, 2012

The following table presents sales and segment profit by business segment reconciled to earnings before income taxes, for the three and six months ended January 31, 2012 and January 31, 2011.



	Three Months Ended				Six Months Ended
	Jan 31, 2012		Jan 31, 2011		Jan 31, 2012		Jan 31, 2011
SALES:
Life Sciences	$	357,165	$	334,214	$	713,298	$	645,794
Industrial	340,816		311,018		690,324		604,915
Total	$	697,981	$	645,232	$	1,403,622	$	1,250,709
SEGMENT PROFIT:
Life Sciences	$	88,706	$	83,650	$	177,688	$	156,838
Industrial	52,480		47,942		100,621		93,281
Total segment profit	141,186		131,592		278,309		250,119
Corporate Services Group	17,678		16,980		33,379		29,301
Operating profit	123,508		114,612		244,930		220,818
ROTC	5,813		4,789		28,797		6,198
Interest expense, net	5,386		5,814		11,331		13,108
Earnings before income taxes	$	112,309	$	104,009	$	204,802	$	201,512

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details